Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 136539, 8 pages
http://dx.doi.org/10.1155/2013/136539
Research Article

The Natural Stilbenoid Piceatannol Decreases Activity and Accelerates Apoptosis of Human Neutrophils: Involvement of Protein Kinase C

1Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, 841 04 Bratislava, Slovakia
2National Transfusion Service, Limbová 3, 831 01 Bratislava, Slovakia

Received 19 July 2013; Accepted 11 September 2013

Academic Editor: Tullia Maraldi

Copyright © 2013 Viera Jancinova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Djoko, R. Y. Y. Chiou, J. J. Shee, and Y. W. Liu, “Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages,” Journal of Agricultural and Food Chemistry, vol. 55, no. 6, pp. 2376–2383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Daikonya and S. Kitanaka, “Polyphenols from Sophora yunnanensis, and their inhibitory effects on nitric oxide production,” Chemical and Pharmaceutical Bulletin, vol. 59, no. 12, pp. 1567–1569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Szekeres, P. Saiko, M. Fritzer-Szekeres, B. Djavan, and W. Jäger, “Chemopreventive effects of resveratrol and resveratrol derivatives,” Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 89–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Piotrowska, M. Kucinska, and M. Murias, “Biological activity of piceatannol: leaving the shadow of resveratrol,” Mutation Research, vol. 750, no. 1, pp. 60–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Richard, D. Porath, A. Radspieler, and J. Schwager, “Effects of resveratrol, piceatannol, triacetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes,” Molecular Nutrition and Food Research, vol. 49, no. 5, pp. 431–442, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Schymeinsky, A. Mócsai, and B. Walzog, “Neutrophil activation via β2 integrins (CD11/CD18): molecular mechanisms and clinical implications,” Thrombosis and Haemostasis, vol. 98, no. 2, pp. 262–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Kim, H. S. Kwon, D. H. Kim et al., “Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis,” International Immunopharmacology, vol. 8, no. 12, pp. 1695–1702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Ennaciri and D. Girard, “IL-4Rα, a new member that associates with Syk kinase: implication in IL-4-induced human neutrophil functions,” The Journal of Immunology, vol. 183, no. 8, pp. 5261–5269, 2009. View at Publisher · View at Google Scholar
  9. N. Ozaki, S. Suzuki, M. Ishida et al., “Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis,” International Immunology, vol. 24, no. 9, pp. 539–550, 2012. View at Publisher · View at Google Scholar
  10. R. Cascão, H. S. Rosário, M. M. Souto-Carneiro, and J. E. Fonseca, “Neutrophils in rheumatoid arthritis: more than simple final effectors,” Autoimmunity Reviews, vol. 9, no. 8, pp. 531–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. L. Wright, R. J. Moots, R. C. Bucknall, and S. W. Edwards, “Neutrophil function in inflammation and inflammatory diseases,” Rheumatology, vol. 49, no. 9, pp. 1618–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Bedard and K. H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. D. McLaughlin, A. Banerjee, and C. C. Silliman, “Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation,” Journal of Leukocyte Biology, vol. 78, no. 5, pp. 1025–1042, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. El-Benna, P. M. C. Dang, and A. Périanin, “Towards specific NADPH oxidase inhibition by small synthetic peptides,” Cellular and Molecular Life Sciences, vol. 69, no. 4, pp. 2307–2314, 2012. View at Publisher · View at Google Scholar
  15. H. R. Luo and F. Loison, “Constitutive neutrophil apoptosis: mechanisms and regulation,” American Journal of Hematology, vol. 83, no. 4, pp. 288–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Witko-Sarsat, M. Pederzoli-Ribeil, E. Hirsh, S. Sozzani, and M. A. Cassatella, “Regulating neutrophil apoptosis: new players enter the game,” Trends in Immunology, vol. 32, no. 3, pp. 117–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, and A. Karlsson, “Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?” Free Radical Biology and Medicine, vol. 49, no. 12, pp. 1834–1845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Björnsdottir, D. Granfeldt, A. Welin, J. Bylund, and A. Karlsson, “Inhibition of phospholipase A2 abrogates intracellular processing of NADPH-oxidase derived reactive oxygen species in human neutrophils,” Experimental Cell Research, vol. 319, no. 5, pp. 761–774, 2013. View at Publisher · View at Google Scholar
  19. D. El Kebir and J. G. Filep, “Role of neutrophil apoptosis in the resolution of inflammation,” TheScientificWorldJournal, vol. 10, pp. 1731–1748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Fox, A. E. Leitch, R. Duffin, C. Haslett, and A. G. Rossi, “Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease,” Journal of Innate Immunity, vol. 2, no. 3, pp. 216–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. C. Dang, A. Fontayne, J. Hakim, J. El Benna, and A. Périanin, “Protein kinase C ζ phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst,” The Journal of Immunology, vol. 166, no. 2, pp. 1206–1213, 2001. View at Google Scholar · View at Scopus
  22. A. Fontayne, P. M. C. Dang, M. A. Gougerot-Pocidalo, and J. El Benna, “Phosphorylation of p47phox sites by PKC α, βII, δ, and ζ: effect on binding to p22phox and on NADPH oxidase activation,” Biochemistry, vol. 41, no. 24, pp. 7743–7750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. L. E. Kilpatrick, S. Sun, D. M. Mackie, F. Baik, H. Li, and H. M. Korchak, “Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of δ-PKC and ERK1/2,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1512–1521, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. E. Kilpatrick, S. Sun, H. Li, T. C. Vary, and H. M. Korchak, “Regulation of TNF-induced oxygen radical production in human neutrophils: role of δ-PKC,” Journal of Leukocyte Biology, vol. 87, no. 1, pp. 153–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Bertram and K. Ley, “Protein kinase C isoforms in neutrophil adhesion and activation,” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 2, pp. 79–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Perečko, V. Jančinová, K. Drábiková et al., “Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene,” Neuroendocrinology Letters, vol. 29, no. 5, pp. 802–805, 2008. View at Google Scholar
  27. K. Drábiková, T. Perečko, R. Nosál' et al., “Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis,” Pharmacological Research, vol. 59, no. 6, pp. 399–403, 2009. View at Publisher · View at Google Scholar
  28. K. Drábiková, V. Jančinová, R. Nosál' et al., “Inhibitory effect of stobadine on FMLP-induced chemiluminescence in human whole blood and isolated polymorphonuclear leukocytes,” Luminescence, vol. 22, pp. 67–71, 2007. View at Google Scholar
  29. V. Jančinová, T. Perečko, R. Nosál' et al., “Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition,” European Journal of Pharmacology, vol. 612, no. 1–3, pp. 161–166, 2009. View at Publisher · View at Google Scholar
  30. R. Nosál', T. Perečko, V. Jančinová et al., “Suppression of oxidative burst in human neutrophils with the naturally occurring serotonin derivative isomer from Leuzea carthamoides,” Neuroendocrinology Letters, vol. 31, pp. 69–72, 2010. View at Google Scholar
  31. V. Jančinová, T. Perečko, R. Nosáľ et al., “The natural stilbenoid pinosylvin and activated neutrophils: effects on oxidative burst, protein kinase C, apoptosis and efficiency in adjuvant arthritis,” Acta Pharmacologica Sinica, vol. 33, pp. 1285–1292, 2012. View at Publisher · View at Google Scholar
  32. T. Perečko, K. Drábiková, L. Račková et al., “Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro,” Neuroendocrinology Letters, vol. 31, pp. 84–90, 2010. View at Google Scholar
  33. R. Nosáľ, T. Perečko, V. Jančinová et al., “Naturally appearing N-feruloylserotonin isomers suppress oxidative burst of human neutrophils at the protein kinase C level,” Pharmacological Reports, vol. 63, pp. 790–798, 2011. View at Google Scholar
  34. C. N. Serhan, “Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 44–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Kohli and B. D. Levy, “Resolvins and protectins: mediating solutions to inflammation,” British Journal of Pharmacology, vol. 158, no. 4, pp. 960–971, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. G. Filep and D. El Kebir, “Neutrophil apoptosis: a target for enhancing the resolution of inflammation,” Journal of Cellular Biochemistry, vol. 108, no. 5, pp. 1039–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Augustyniak, G. Bartosz, A. Čipak et al., “Natural and synthetic antioxidants: an updated overview,” Free Radical Research, vol. 44, no. 10, pp. 1216–1262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Stefek, “Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract,” Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69–77, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Bauerová, S. Poništ, D. Mihalová et al., “Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress,” Interdisciplinary Toxicology, vol. 4, pp. 33–39, 2011. View at Google Scholar
  40. M. Číž, M. Pavelková, L. Gallová, J. Králová, L. Kubala, and A. Lojek, “The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7,” Physiological Research, vol. 57, no. 3, pp. 393–402, 2008. View at Google Scholar · View at Scopus
  41. M. Ciz, P. Denev, M. Kratchanova, O. Vasicek, G. Ambrozova, and A. Lojek, “Flavonoids inhibit the respiratory burst of neutrophils in mammals,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 181295, 6 pages, 2012. View at Publisher · View at Google Scholar
  42. L. Camont, F. Collin, M. Couturier et al., “Radical-induced oxidation of trans-resveratrol,” Biochimie, vol. 94, no. 3, pp. 741–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. J. Slater, J. L. Seiz, A. C. Cook, B. A. Stagliano, and C. J. Buzas, “Inhibition of protein kinase C by resveratrol,” Biochimica et Biophysica Acta, vol. 1637, no. 1, pp. 59–69, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. A. Mahmmoud, “Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions,” British Journal of Pharmacology, vol. 150, no. 2, pp. 200–208, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Varga, I. Seres, E. Nagy et al., “Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro,” Phytomedicine, vol. 13, no. 1-2, pp. 85–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Gopalakrishna and U. Gundimeda, “Antioxidant regulation of protein kinase C in cancer prevention,” Journal of Nutrition, vol. 132, no. 12, pp. 3819S–3823S, 2002. View at Google Scholar · View at Scopus
  47. O. Wesołowska, M. Kuzdzał, J. Štrancar, and K. Michalak, “Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes,” Biochimica et Biophysica Acta, vol. 1788, no. 9, pp. 1851–1860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. D. Matute, A. A. Arias, M. C. Dinauer, and P. J. Patiño, “p40phox: the last NADPH oxidase subunit,” Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 291–302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. J. D. Matute, A. A. Arias, N. A. M. Wright et al., “A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity,” Blood, vol. 114, no. 15, pp. 3309–3315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. G. E. Brown, M. Q. Stewart, H. Liu, V. L. Ha, and M. B. Yaffe, “A novel assay system implicates PtdIns(3,4)P2, PtdIns(3)P, and PKCδ in intracellular production of reactive oxygen species by the NADPH oxidase,” Molecular Cell, vol. 11, no. 1, pp. 35–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. M. B. Raeder, P. J. Mansfield, V. Hinkovska-Galcheva, J. A. Shayman, and L. A. Boxer, “Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis,” The Journal of Immunology, vol. 163, no. 12, pp. 6785–6793, 1999. View at Google Scholar · View at Scopus
  52. K. H. Choi, J. E. Kim, N. R. Song et al., “Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells,” Cardiovascular Research, vol. 85, no. 4, pp. 836–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. P. R. Webb, K. Q. Wang, D. Scheel-Toellner, J. Pongracz, M. Salmon, and J. M. Lord, “Regulation of neutrophil apoptosis: a role for protein kinase C and phosphatidylinositol-3-kinase,” Apoptosis, vol. 5, no. 5, pp. 451–458, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. H. Kim, C. Park, J. O. Lee et al., “Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases,” Oncology Reports, vol. 19, no. 4, pp. 961–967, 2008. View at Google Scholar · View at Scopus
  55. C. H. Kang, D. O. Moon, Y. H. Choi et al., “Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation,” Toxicology in Vitro, vol. 25, no. 3, pp. 605–612, 2011. View at Publisher · View at Google Scholar · View at Scopus